The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Open accessAbstract
Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biological systems and are consequently implicated in the development of disease states. Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clinical development. In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class. For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The inhibition of PPIs has arguably received more attention in the past and has proved to be challenging but still feasible.2,3”
From Chasing molecular glue degraders: screening approaches (2022) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 4,196
Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A. C., Mínguez, P., Doerks, T., Stark, M., Muller, J., Bork, P., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq973 · Cited by 3,469
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Principles of protein-protein interactions
Jones, S., & Thornton, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.13 · Cited by 2,684
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S. I., & Price, D. A. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 2,034
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 2,002
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Anatomy of hot spots in protein interfaces
Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,001
Characterization of the Binding of Small Molecules to Intrinsically Disordered Proteins
Dobrev, V. S., Fred, L. M., Gerhart, K. P., & Metallo, S. J. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.09.033 · Cited by 16
Sanad, S. M. H., Ahmed, A. A. M., & Mekky, A. E. M. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144647 · Cited by 13
de Moraes, B. C., Filho, H. V. R., Roldão, A. P., Toniolo, E. F., Carretero, G., Sgro, G. G., Batista, F. A. H., Berardi, D. E., Oliveira, V. R. D. S., Tomasin, R., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abm6046 · Cited by 13
Fan, C., Zhang, Z., Lai, Z., Yang, Y., Li, J., Liu, L., Chen, S., Hu, X., Zhao, H., & Cui, S. (2023) · Advanced Science · doi:10.1002/advs.202305432 · Cited by 17
Chemical screening by time-resolved X-ray scattering to discover allosteric probes
Brosey, C. A., Link, T. M., Shen, R., Moiani, D., Burnett, K. H., Hura, G. L., Jones, D. E., & Tainer, J. A. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01609-1 · Cited by 13
Qin, X., Hou, R., Qu, Z., Yu, J., Zhang, W., Ma, H., & Zhuang, C. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108350 · Cited by 14
Xie, J., Zhang, Y., Wang, Z., Jin, X., Lü, X., Ge, S., & Min, X. (2025) · BMC Bioinformatics · doi:10.1186/s12859-025-06123-2 · Cited by 15
Transglutaminase-mediated cross-linking of WDR54 regulates EGF receptor-signaling
Maeda, A., Nishino, T., Matsunaga, R., Yokoyama, A., Suga, H., Yagi, T., & Konishi, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.11.009 · Cited by 13
Wang, N., Jiang, Y., Peng, P., Liu, G., Qi, S., Liu, K., Mei, Q., & Li, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4571319 · Cited by 13
Song, C., Yuan, Y., Zhou, J., He, Z., Hu, Y., Xie, Y., Liu, N., Wu, L., & Zhang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878937 · Cited by 13
Li, X., Sun, B., Zhu, J., Qian, M., & Chen, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04989 · Cited by 13
Jiang, Z., Kuo, Y.-H., Zhong, M., Zhang, J., Zhou, X. X., Xing, L., Wells, J. A., Wang, Y., & Arkin, M. R. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c03665 · Cited by 13
Gu, J., Peng, R.-K., Guo, C., Zhang, M., Yang, J., Yan, X. H., Zhou, Q., Li, H., Wang, N., Zhu, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34598-7 · Cited by 15
Desrochers, G. F., Cornacchia, C., McKay, C. S., & Pezacki, J. P. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00047 · Cited by 13
Bartus, É., Olajos, G., Schuster, I., Bozsó, Z., Deli, M. A., Veszelka, S., Walter, F. R., Datki, Z., Szakonyi, Z., Martinek, T. A., et al. (2018) · Molecules · doi:10.3390/molecules23102523 · Cited by 12
Drug Design of “Undruggable” Targets
Wang, J., Li, S., & Li, H. (2019) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201800552 · Cited by 13
BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation
Cui, H., Guo, W., Zhang, B., Li, G., Li, T., Yuan, Y., Zhang, N., Yang, Y., Feng, W., Chu, F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164062 · Cited by 13
Sengupta, A., Liriano, J., Miller, B. G., & Frederich, J. H. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00795 · Cited by 13
Zhang, F., Zhang, Y., Kong, L., Luo, H., Zhang, Y., Mäkilä, E. M., Salonen, J., Hirvonen, J. J., Zhu, Y., Cheng, Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109131 · Cited by 13
GM-Pep: A High Efficiency Strategy to De Novo Design Functional Peptide Sequences
Chen, Q., Yang, C., Xie, Y., Wang, Y., Li, X., Wang, K., Huang, J., & Yan, W. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00089 · Cited by 12
Liao, Y., Chan, S. C., Welsh, E. A., Fang, B., Sun, L., Schönbrunn, E., Koomen, J. M., Duckett, D. R., Haura, E. B., Monastyrskyi, A., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00587 · Cited by 12
Catara, G., Caggiano, R., & Palazzo, L. (2023) · Pathogens · doi:10.3390/pathogens12020240 · Cited by 12
The case for complement component 5 as a target in neurodegenerative disease
Stennett, A., Friston, K., Harris, C. L., Wollman, A. J. M., Bronowska, A. K., & Madden, K. S. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2177532 · Cited by 12
SCARdock: A Web Server and Manually Curated Resource for Discovering Covalent Ligands
Song, Q., Zeng, L., Zheng, Q., & Liu, S. (2023) · ACS Omega · doi:10.1021/acsomega.2c08147 · Cited by 11
Nguyen, M. H., Tran, N. D., & Le, N. Q. K. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230913105829 · Cited by 10
Deng, Y., Chen, X., Zhang, Z., Zhao, X., Zhu, Z., Wu, C., Chen, Y., Li, C., Sun, L., Zhou, Y., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152398 · Cited by 12
Liu, Y., Sundah, N. R., Ho, N. R. Y., Shen, W. X., Xu, Y., Natalia, A., Yu, Z., Seet, J. E., Chan, C. W., Loh, T. P., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01225-3 · Cited by 13
Wei, J., Liu, Z., Li, M., Du, L., Zhu, X., Leng, Y., Han, C., Xu, Q., & Zhang, C. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s467066 · Cited by 12
Neupane, R., Malla, S., Karthikeyan, C., Asbhy, C. R., Boddu, S. H. S., Babu, R. J., & Tiwari, A. K. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125356 · Cited by 12
Water in drug design: pitfalls and good practices
Zsidó, B. Z., & Hetényi, C. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2497912 · Cited by 12
Michelet, B., Carreyre, H., Lecornué, F., Martin‐Mingot, A., & Thibaudeau, S. (2018) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2018.04.017 · Cited by 14
Predicting Protein–Protein Interactions Using Symmetric Logistic Matrix Factorization
Pei, F., Shi, Q., Zhang, H., & Bahar, İ. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00173 · Cited by 14
Hu, K., Li, X., Asmamaw, M. D., Shi, X., & Liu, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-00646-3 · Cited by 12
Effective synthesis of new benzo-fused macrocyclic and heteromacrocyclic bis(Schiff bases)
Ahmed, A. A. M., Mekky, A. E. M., & Sanad, S. M. H. (2021) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-021-02409-3 · Cited by 12
Wu, J., Power, H., Saksena, M. M., Valtchev, P., Schindeler, A., Cunningham, A. L., & Dehghani, F. (2022) · Pharmaceuticals · doi:10.3390/ph15030361 · Cited by 12
Small molecules to regulate the GH/IGF1 axis by inhibiting the growth hormone receptor synthesis
van der Velden, L. M., Maas, P., van Amersfoort, M., Timmermans‐Sprang, E. P. M., Mensinga, A., van der Vaart, E. D., Malergue, F., Viëtor, H. E., Derksen, P. W. B., Klumperman, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.926210 · Cited by 12
A Flexible, Modular Platform for Multidimensional Ion Mobility of Native-like Ions
Eaton, R. M., Zercher, B. P., Wageman, A., & Bush, M. F. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00112 · Cited by 12
A Sensitive, Semi-Quantitative Mammalian Two-Hybrid Assay
Riegel, E., Heimbucher, T., Höfer, T., & Czerny, T. (2017) · BioTechniques · doi:10.2144/000114544 · Cited by 12
Villa, S., Legnani, L., Colombo, D., Gelain, A., Lammi, C., Bongiorno, D., Ilboudo, D. P., McGee, K., Bosch, J., & Grazioso, G. (2018) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-018-0102-5 · Cited by 12
Schopp, I. M., & Béthune, J. (2018) · Journal of Visualized Experiments · doi:10.3791/57479 · Cited by 12
Jing, Q., Chen, A., & Zhao, N. (2018) · Physical Chemistry Chemical Physics · doi:10.1039/c8cp05203d · Cited by 12
Ito, S., Saito, M., Yoshida, M., Takeuchi, K., Doi, T., & Nagata, K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010567 · Cited by 12
Lyu, N., Wang, K., Zhang, F., Qin, H.-M., Zhao, Y., Wu, R., Si, Y., & Wang, L. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp05531b · Cited by 12
Leo, F. D., Quilici, G., Marchis, F. D., Mantonico, M. V., Bianchi, M. E., & Musco, G. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.598710 · Cited by 11
Structural insights into Beclin 1 interactions with it's regulators for autophagy modulation
Sarmadhikari, D., & Asthana, S. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.06.044 · Cited by 13
Qu, H., Ning, L., An, R., Fan, W., Derr, T., Liu, H., Xin, X., & Li, Q. (2026) · ACM Transactions on Intelligent Systems and Technology · doi:10.1145/3819582 · Cited by 127
Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics
Baby, S., Shinde, S. D., Kulkarni, N., & Sahu, B. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00386 · Cited by 11
A Tumor‐Specific Cascade‐Activating Smart Prodrug System for Enhanced Targeted Therapy
Wang, Q., Jin, D., Liu, C., Shi, L., & Li, T. (2023) · Small · doi:10.1002/smll.202309482 · Cited by 11
Cai, G., Bao, Y., Li, Q., Hsu, P., Xia, J., & Ngo, J. C. K. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01230-2 · Cited by 11
Dapiaggi, F., Pieraccini, S., Potenza, D., Vasile, F., Macut, H., Pellegrino, S., Aliverti, A., & Sironi, M. (2017) · New Journal of Chemistry · doi:10.1039/c6nj04014d · Cited by 11
Yang, R. X., Liu, S., Wu, Z., Tan, Y. C., & Sun, S. (2018) · Talanta · doi:10.1016/j.talanta.2018.01.070 · Cited by 11
A simple fluorescent assay for the discovery of protein-protein interaction inhibitors
Al‐Mugotir, M., Kolar, C., Vance, K. E., Kelly, D. L., Natarajan, A., & Borgstahl, G. E. O. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.01.010 · Cited by 11
Water envelope has a critical impact on the design of protein–protein interaction inhibitors
Ratkova, E. L., Dawidowski, M., Napolitano, V., Dubin, G., Fino, R., Ostertag, M. S., Sattler, M., Popowicz, G. M., & Tetko, I. V. (2020) · Chemical Communications · doi:10.1039/c9cc07714f · Cited by 11
Hymel, D., Tsuji, K., Grant, R. A., Chingle, R. M., Kunciw, D. L., Yaffe, M. B., & Burke, T. R. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob01120k · Cited by 11
Ahmed, A. A. M., Mekky, A. E. M., & Sanad, S. M. H. (2021) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4383 · Cited by 11
Gan, Y., Li, Y., Zhou, H., & Wang, R. (2022) · Organic Letters · doi:10.1021/acs.orglett.2c02662 · Cited by 11
Miyamoto‐Sato, E., Imanishi, S., Huang, L., Itakura, S., Iwasaki, Y., & Ishizaka, M. (2023) · Molecules · doi:10.3390/molecules28145600 · Cited by 13
Identification and characterization of a novel Sso7d scaffold-based binder against Notch1
Gocha, T., Rao, B. M., & DasGupta, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-12246-1 · Cited by 11
Feng, M., Li, Y., Chen, X., Wei, Q., Wu, W., & Hu, Z. (2017) · Toxins · doi:10.3390/toxins10010007 · Cited by 11
Synthetic fermentation of β-peptide macrocycles by thiadiazole-forming ring-closing reactions
Hubert, J. G., Stepek, I. A., Noda, H., & Bode, J. W. (2018) · Chemical Science · doi:10.1039/c7sc05057g · Cited by 11
Gervais, V., Muller, I., Mari, P., Mourcet, A., Movellan, K. T., Ramos, P., Marcoux, J., Guillet, V., Javaid, S., Burlet‐Schiltz, O., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003444 · Cited by 11
Kreamer, N. N. K., Chopra, R., Caughlan, R. E., Fabbro, D., Fang, E., Gee, P., Hunt, I., Li, M., Leon, B. C., Muller, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32379-1 · Cited by 10
Developing RNA Aptamers for Potential Treatment of Neurological Diseases
Huang, Z., & Niu, L. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0364 · Cited by 11
Ma, X., Zhu, M., Liu, J., Li, X., Qu, L., Liang, L., Huang, W., Wang, J., Li, N., Chen, J., et al. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00665 · Cited by 11
Higo, J., Takashima, H., Fukunishi, Y., & Yoshimori, A. (2021) · Journal of Computational Chemistry · doi:10.1002/jcc.26516 · Cited by 11
Xu, L., Xu, N., Wang, L., Qian, H., Li, Y., Fang, M., Xiang, Z., Lin, W., Zhang, F., Shao, Q., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.06.025 · Cited by 10
WNK Signaling Inhibitors as Potential Antihypertensive Drugs
Alamri, M. A., Kadri, H., Dhiani, B. A., Mahmood, S., Elzwawi, A., & Mehellou, Y. (2017) · ChemMedChem · doi:10.1002/cmdc.201700425 · Cited by 11
Transfer factor I: methods of therapy.
Levin, A. S., S̄pitler, L. E., & Fudenberg, H. H. (1975) · PubMed · Cited by 11
Unleashing the power of DNA-encoded libraries for challenging targets in drug discovery
Du, N., Li, Y., Lou, Q., Zhang, G., Li, Y., & Li, Y. (2026) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2026.100115 · Cited by 10
Zhou, L., Jeong, I. H., Xue, S., Xue, M., Wang, L., Li, S., Liu, R., Jeong, G. H., Wang, X., Cai, J., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01459 · Cited by 10
Laval, F., Coppin, G., Twizere, J., & Vidal, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119179 · Cited by 10
A novel universal small-molecule detection platform based on antibody-controlled Cas12a switching
Sun, T., Wang, W., Wang, F., Shen, W., Geng, L., Zhang, Y., Bi, M., Gong, T., Liu, C., Guo, C., et al. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115897 · Cited by 10
Neto, J. X., Bezerra, K. S., Barbosa, E. D., Araujo, R. L., Galvao, D. S., Lyra, M. L., Oliveira, J. I. N., Akash, S., Jardan, Y. A. B., Nafidi, H., et al. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1325588 · Cited by 11
Hec, A., Tyrcha, U., Barczyński, J., Bielski, P., Mikitiuk, M., Gudz, G. P., Kitel, R., Musielak, B., Plewka, J., Sitar, T., et al. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00042 · Cited by 11
Cawood, E. E., Baker, E. G., Edwards, T. A., Woolfson, D. N., Karamanos, T. K., & Wilson, A. J. (2024) · Chemical Science · doi:10.1039/d4sc02240h · Cited by 10
DNA-modulated dimerization and oligomerization of cell membrane receptors
Ali, A. A., & You, M. (2024) · Chemical Communications · doi:10.1039/d4cc03077j · Cited by 10
TBL2 Promotes Tumorigenesis via PRMT5/WDR77‐Mediated AKT Activation in Breast Cancer
Lu, X., Zhang, C., Zhu, L., Wang, S., Zeng, L., Zhong, W., Wu, X., Yuan, Q., Tang, H., Cui, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202400160 · Cited by 10
Lin, C., Narayanan, D., Barreca, M., Poulsen, C., da Costa, L. S., Chen, X., Wichman, K. G., Charley, C. A., Lindsay, J. L., Dezfouli, M., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202508121 · Cited by 14
Mimicry of a β-Hairpin Turn by a Nonpeptidic Laterally Flexible Foldamer
Meisel, J. W., Hu, C. T., & Hamilton, A. D. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b01463 · Cited by 10
Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2
Bittremieux, W., Adams, C., Laukens, K., Dorrestein, P. C., & Bandeira, N. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00929 · Cited by 11
Peptide macrocyclisation via late-stage reductive amination
Bell, H. J., & Malins, L. R. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d2ob00782g · Cited by 10
Tubiana, J., Lifshits, L. A., Nissan, M., Gabay, M., Sher, I., Sova, M., Wolfson, H. J., & Gal, M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010874 · Cited by 12
AAA ATPase protein–protein interactions as therapeutic targets in cancer
Mannar, D., Ahmed, S., & Subramaniam, S. (2023) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2023.102291 · Cited by 10
Megalin‐related mechanism of hemolysis‐induced acute kidney injury and the therapeutic strategy
Goto, S., Hosojima, M., Kabasawa, H., Arai, K., Takemoto, K., Aoki, H., Komochi, K., Kobayashi, R., Sugita, N., Endo, T., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6284 · Cited by 10
What is the Future for Fragment-Based Drug Discovery?
Keserű, G. M., & Hann, M. M. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0106 · Cited by 10
Analysis of Borrelia burgdorferi Proteome and Protein–Protein Interactions
Yang, X., Thakur, M., Koči, J., Smith, A. A., Singh, P., Zhuang, X., Promnares, K., Wang, Y., Büyüktanır, Ö., & Pal, U. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7383-5_19 · Cited by 10
Huang, J., Wu, R., Wu, C., Liu, D., Zhang, J., Liao, B., Lei, M., Xiao, X., Ma, C., & He, H. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.11.009 · Cited by 10
Tri‐Orthogonal Scaffolds for the Solid‐Phase Synthesis of Peptides
Pícha, J., Fabre, B., Buděšı́nský, M., Hajduch, J., Abdellaoui, M., & Jiráček, J. (2018) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201800601 · Cited by 10
Wales, S. M., Adcock, H. V., Lewis, W., Hamza, D., & Moody, C. J. (2018) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201800962 · Cited by 10
Queiroz, F. C., Vargas, A. M. P., Oliveira, M. G. A., Comarela, G., & Silveira, S. D. A. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3474-1 · Cited by 10
Xu, Y., Liu, R., Leu, N. A., Zhang, L., Ibragmova, I., Schultz, D., & Wang, P. J. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa062 · Cited by 10
Stavridi, A. K., Appleby, R. E., Liang, S., Blundell, T. L., & Chaplin, A. K. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190092 · Cited by 10
Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway
Álvarez-Coiradas, E., Munteanu, C. R., Saez, L. D., Pazos, A., Huber, K., Loza, M. I., & Domínguez, E. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107026 · Cited by 10
Mulnaes, D., Golchin, P., Koenig, F., & Gohlke, H. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00129 · Cited by 10
Trobe, M., Schreiner, T., Vareka, M., Grimm, S., Wölfl, B., & Breinbauer, R. (2022) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202101280 · Cited by 9
Shulga, D. A., & Kudryavtsev, K. V. (2022) · Molecules · doi:10.3390/molecules27238182 · Cited by 10
The impact of structural biology in medicine illustrated with four case studies
Hu, T., Sprague, E. R., Fodor, M., Stams, T., Clark, K., & Cowan‐Jacob, S. W. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1565-x · Cited by 11
Long-Term In Vivo Molecular Monitoring Using Aptamer-Graphene MicrotransistorsPreprint
Wu, G., Zhang, E. T., Qiang, Y., Esmonde, C., Chen, X., Wei, Z., Song, Y., Zhang, X., Schneider, M. J., Li, H., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.18.562080 · Cited by 11
Xu, Y., Zeng, C., Wen, H., Shi, Q., Zhao, X., Meng, Q., Li, X., & Xiao, J. (2023) · Pharmaceuticals · doi:10.3390/ph16050737 · Cited by 9
Peng, Q., & Weerapana, E. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.11.010 · Cited by 9
Metadata
- Authors
- Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Abell, Chris
- Skidmore, John
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-04-11
- Volume
- 15
- Issue
- 8
- Pages
- 533-550
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2329592726
- Cited by
- 1,137
- References
- 172
- Citations by year
- 2026: 101 · 2025: 121 · 2024: 120 · 2023: 115 · 2022: 117 · 2021: 128 · 2020: 120 · 2019: 106 · 2018: 107 · 2017: 83 · 2016: 16
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- protein-protein interaction, PPI inhibitors, small molecule drug discovery, drug target identification, structure-based drug design
- MeSH terms
- Animals, Humans, Models, Molecular, Proteins, Protein Structure, Tertiary, Computational Biology, Protein Interaction Domains and Motifs, Small Molecule Libraries, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review